Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Pittsburgh
Lumos Pharma
Actuate Therapeutics Inc.
iOnctura
Merck Sharp & Dohme LLC
Chinese PLA General Hospital
Verastem, Inc.
Australasian Gastro-Intestinal Trials Group